Skip to main content
. Author manuscript; available in PMC: 2020 Mar 15.
Published in final edited form as: Cancer. 2018 Dec 18;125(6):902–909. doi: 10.1002/cncr.31872

Table 2.

Grade 3/4 Adverse Effects.

Grade 3/4 Adverse Effects
Non-Hematological N %
Hypertension 10 23
Fatigue 4 9
Abdominal pain 4 9
Generalized Pain 4 9
Rash/ maculo-papular 3 7
Nausea 3 7
Hematological
Hypophosphatemia 17 40
Hyperbilirubinemia 11 26
Hyponatremia 9 21
Lymphocytopenia 8 19
Thrombocytopenia 6 14
Aspartate aminotransferase increased 6 14
Alkaline phosphatase increased 6 14
Hypokalemia 5 12
Anemia 5 12
Alanine aminotransferase increased 5 12
Lipase increased 3 7
Hypoalbuminemia 3 7